van Doorn, E. et al., Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001): phase IIb study protocol, Medicine 96(11):e6339 (2017)

Cited by name. No followable URL — the bibliographic record is the citation.

Authors. van Doorn, E. et al

Venue. Medicine

How the Institute flags it

established 1 time

Cited on 1 page

• Universal Vaccines